Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets


ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Review Article

Emerging Therapeutic Effects of Herbal Plants in Rheumatoid Arthritis

Author(s): Rashita Makkar, Tapan Behl*, Arun Kumar, Priya Nijhawan and Sandeep Arora

Volume 21, Issue 4, 2021

Published on: 20 June, 2020

Page: [617 - 625] Pages: 9

DOI: 10.2174/1871530320666200620232828

Price: $65


Rheumatoid arthritis is a chronic inflammatory autoimmune disease characterized by the failure of spontaneous resolution of inflammation with lifetime perseverance, becoming one of the major causes of disability in millions of people. It is mainly characterized by progressive erosion of cartilage in response to the formation of pannus leading to chronic polyarthritis and joint distortion. Early diagnosis and advances in molecular biology undoubtedly revolutionized therapeutic interventions in the past decade for better disease management. Despite favorable prospects, many patients still fail to respond to the current therapies urging a burning need to develop newer and safer medications. Herbal plants have been utilized since the ancient era and provided the base for massive bioactive compounds with flaunting therapeutic potential, many being advanced to drugs that are consumed worldwide for treating countless ailments. Scientific studies showed the involvement of several cellular mechanisms like oxidative stress suppression, downregulated synthesis of proinflammatory cytokines namely interleukins (IL-1, IL-6), TNF-α, NF-κB, demoted metalloproteinases induced cartilage destruction and augmentation of free radical scavenging and antioxidant activity in the treatment of rheumatoid arthritis. A plethora of active phytoconstituents like flavonoids, saponins, terpenes, alkaloids, lactones, etc, have been isolated from herbal plants with proven curative actions. The present review enlists some of the herbal drugs that can be used to amend the effects of rheumatoid arthritis and impart symptomatic relief to patients.

Keywords: Rheumatoid, arthritis, curcuma longa, zingiber officinale, vatari guggulu, punica granatum, herbal plants.

Graphical Abstract
Choudhary, M.; Kumar, V.; Malhotra, H.; Singh, S. Medicinal plants with potential anti-arthritic activity. J. Intercult. Ethnopharmacol., 2015, 4(2), 147-179.
[] [PMID: 26401403]
Gupta, M. Natural products in treatment of rheumatoid arthritis., Int. J. Green Pharm., 2017, 11(3).
Kumar, S.S.; Bhosle, D.; Janghel, A.; Deo, S.; Raut, P. Indian medicinal plants used for treatment of rheumatoid arthritis. Research J. Pharm. and Tech., 2015, 8(5), 597.
Farzaei, M.H.; Farzaei, F.; Abdollahi, M.; Abbasabadi, Z.; Abdolghaffari, A.H.; Mehraban, B. A mechanistic review on medicinal plants used for rheumatoid arthritis in traditional Persian medicine. J. Pharm. Pharmacol., 2016, 68(10), 1233-1248.
[] [PMID: 27417522]
Tak, P.P.; Bresnihan, B. The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis. Arthritis Rheum., 2000, 43(12), 2619-2633.
[<2619:AID-ANR1>3.0.CO;2-V] [PMID: 11145019]
Gibofsky, A. Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis., Am. J. Manag. Care, 2012, 18(13), (Suppl.), S295-S302..
[PMID: 23327517]
Moelants, E.A.; Mortier, A.; Van Damme, J.; Proost, P. Regulation of TNF-α with a focus on rheumatoid arthritis. Immunol. Cell Biol., 2013, 91(6), 393-401.
[] [PMID: 23628802]
Trowsdale, J.; Knight, J.C. Major histocompatibility complex genomics and human disease. Annu. Rev. Genomics Hum. Genet., 2013, 14, 301-323.
[] [PMID: 23875801]
Abi-Rached, L.; Jobin, M.J.; Kulkarni, S.; McWhinnie, A.; Dalva, K.; Gragert, L.; Babrzadeh, F.; Gharizadeh, B.; Luo, M.; Plummer, F.A.; Kimani, J.; Carrington, M.; Middleton, D.; Rajalingam, R.; Beksac, M.; Marsh, S.G.; Maiers, M.; Guethlein, L.A.; Tavoularis, S.; Little, A.M.; Green, R.E.; Norman, P.J.; Parham, P. The shaping of modern human immune systems by multiregional admixture with archaic humans. Science, 2011, 334(6052), 89-94.
[] [PMID: 21868630]
Baky, M.S.; Mohamed, D.F.; Hosney, S.M.; ElSherbiny, D.A.; Gomaa, A.A. Prevalence of pulmonary manifestations in a cohort of the Egyptian patients with rheumatoid arthritis. Egypt. J. Hosp. Med., 2017, 69(3), 2025-2029.
Lawrence, R.C.; Felson, D.T.; Helmick, C.G.; Arnold, L.M.; Choi, H.; Deyo, R.A.; Gabriel, S.; Hirsch, R.; Hochberg, M.C.; Hunder, G.G.; Jordan, J.M.; Katz, J.N.; Kremers, H.M.; Wolfe, F. National arthritis data workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum., 2008, 58(1), 26-35.
[] [PMID: 18163497]
Wolfe, F.; Freundlich, B.; Straus, W.L. Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J. Rheumatol., 2003, 30(1), 36-40.
[PMID: 12508387]
Aletaha, D.; Neogi, T.; Silman, A.J.; Funovits, J.; Felson, D.T.; Bingham, C.O., III; Birnbaum, N.S.; Burmester, G.R.; Bykerk, V.P.; Cohen, M.D.; Combe, B.; Costenbader, K.H.; Dougados, M.; Emery, P.; Ferraccioli, G.; Hazes, J.M.; Hobbs, K.; Huizinga, T.W.; Kavanaugh, A.; Kay, J.; Kvien, T.K.; Laing, T.; Mease, P.; Ménard, H.A.; Moreland, L.W.; Naden, R.L.; Pincus, T.; Smolen, J.S.; Stanislawska-Biernat, E.; Symmons, D.; Tak, P.P.; Upchurch, K.S.; Vencovský, J.; Wolfe, F.; Hawker, G. 2010 Rheumatoid arthritis classification criteria: an American college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum., 2010, 62(9), 2569-2581.
[] [PMID: 20872595]
Helmick, C.G.; Felson, D.T.; Lawrence, R.C.; Gabriel, S.; Hirsch, R.; Kwoh, C.K.; Liang, M.H.; Kremers, H.M.; Mayes, M.D.; Merkel, P.A.; Pillemer, S.R.; Reveille, J.D.; Stone, J.H. National arthritis data workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum., 2008, 58(1), 15-25.
[] [PMID: 18163481]
Remmers, E.F.; Plenge, R.M.; Lee, A.T.; Graham, R.R.; Hom, G.; Behrens, T.W.; de Bakker, P.I.; Le, J.M.; Lee, H.S.; Batliwalla, F.; Li, W.; Masters, S.L.; Booty, M.G.; Carulli, J.P.; Padyukov, L.; Alfredsson, L.; Klareskog, L.; Chen, W.V.; Amos, C.I.; Criswell, L.A.; Seldin, M.F.; Kastner, D.L.; Gregersen, P.K. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N. Engl. J. Med., 2007, 357(10), 977-986.
[] [PMID: 17804842]
Kallberg, H.; Padyukov, L.; Plenge, R.M.; Ronnelid, J.; Gregersen, P.K.; van der Helm-van Mil, A.H.; Toes, R.E.; Huizinga, T.W.; Klareskog, L.; Alfredsson, L. Epidemiological investigation of rheumatoid arthritis study group. Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am. J. Hum. Genet., 2007, 80(5), 867-875.
[] [PMID: 17436241]
McInnes, I.B.; Schett, G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med., 2011, 365(23), 2205-2219.
[] [PMID: 22150039]
Anić, B.; Mayer, M. Pathogenesis of rheumatoid arthritis. Reumatizam, 2014, 61(2), 19-23.
[PMID: 25427390]
Klareskog, L.; Stolt, P.; Lundberg, K.; Källberg, H.; Bengtsson, C.; Grunewald, J.; Rönnelid, J.; Harris, H.E.; Ulfgren, A.K.; Rantapää-Dahlqvist, S.; Eklund, A.; Padyukov, L.; Alfredsson, L. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum., 2006, 54(1), 38-46.
[] [PMID: 16385494]
Rantapää-Dahlqvist, S.; de Jong, B.A.; Berglin, E.; Hallmans, G.; Wadell, G.; Stenlund, H.; Sundin, U.; van Venrooij, W.J. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum., 2003, 48(10), 2741-2749.
[] [PMID: 14558078]
Wadekar, J.B.; Sawant, R.L.; Patel, U.B. Rheumatoid arthritis and herbal drugs: A review. J. Phytopharmacol., 2015, 4(6), 311-318.
Patwardhan, S.K.; Bodas, K.S.; Gundewar, S.S. Coping with arthritis using safer herbal options. Int. J. Pharma Sci., 2010, 2(1), 1-11.
Cooles, F.A.; Isaacs, J.D. Pathophysiology of rheumatoid arthritis. Curr. Opin. Rheumatol., 2011, 23(3), 233-240.
[] [PMID: 21427580]
Firestein, G.S. Evolving concepts of rheumatoid arthritis. Nature, 2003, 423(6937), 356-361.
[] [PMID: 12748655]
Wilkie, W.S.; Schwieterman, P. Strategies for the management of rheumatoid arthritis. Orthopedics, 2012, 35(2), 125-130.
[] [PMID: 22300992]
Rathore, B.; Ali Mahdi, A.; Nath Paul, B.; Narayan Saxena, P.; Kumar Das, S. Indian herbal medicines: possible potent therapeutic agents for rheumatoid arthritis. J. Clin. Biochem. Nutr., 2007, 41(1), 12-17.
[] [PMID: 18392103]
Fernández-Bañares, F.; Salas, A.; Esteve, M.; Espinós, J.; Forné, M.; Viver, J.M. Collagenous and lymphocytic colitis. evaluation of clinical and histological features, response to treatment, and long-term follow-up. Am. J. Gastroenterol., 2003, 98(2), 340-347.
[] [PMID: 12591052]
Tolboom, T.C.; van der Helm-Van Mil, A.H.; Nelissen, R.G.; Breedveld, F.C.; Toes, R.E.; Huizinga, T.W. Invasiveness of fibroblast-like synoviocytes is an individual patient characteristic associated with the rate of joint destruction in patients with rheumatoid arthritis. Arthritis Rheum., 2005, 52(7), 1999-2002.
[] [PMID: 15986342]
Vasanthi, P.; Nalini, G.; Rajasekhar, G. Status of oxidative stress in rheumatoid arthritis. Int. J. Rheum. Dis., 2009, 12(1), 29-33.
[] [PMID: 20374313]
Brzustewicz, E.; Bryl, E. The role of cytokines in the pathogenesis of rheumatoid arthritis-practical and potential application of cytokines as biomarkers and targets of personalized therapy. Cytokine, 2015, 76(2), 527-536.
[] [PMID: 26321413]
García-González, A.; Gaxiola-Robles, R.; Zenteno-Savín, T. Oxidative stress in patients with rheumatoid arthritis. Rev. Invest. Clin., 2015, 67(1), 46-53.
[PMID: 25857584]
Wruck, C.J.; Fragoulis, A.; Gurzynski, A.; Brandenburg, L-O.; Kan, Y.W.; Chan, K.; Hassenpflug, J.; Freitag-Wolf, S.; Varoga, D.; Lippross, S.; Pufe, T. Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice. Ann. Rheum. Dis., 2011, 70(5), 844-850.
[] [PMID: 21173018]
Hadjigogos, K. The role of free radicals in the pathogenesis of rheumatoid arthritis. Panminerva Med., 2003, 45(1), 7-13. 12682616.
Altindag, O.; Karakoc, M.; Kocyigit, A.; Celik, H.; Soran, N. Increased DNA damage and oxidative stress in patients with rheumatoid arthritis. Clin. Biochem., 2007, 40(3-4), 167-171.
[] [PMID: 17196579]
Paleolog, E.M. Angiogenesis in rheumatoid arthritis., Arthritis Res., 2002, 4(3), (Suppl. 3), S81-S90..
[ ] [PMID: 12110126]
Maruotti, N.; Cantatore, F.P.; Crivellato, E.; Vacca, A.; Ribatti, D. Angiogenesis in rheumatoid arthritis. Histol. Histopathol., 2006, 21(5), 557-566.
[PMID: 16493585]
Szekanecz, Z.; Besenyei, T.; Paragh, G.; Koch, A.E. Angiogenesis in rheumatoid arthritis. Autoimmunity, 2009, 42(7), 563-573.
[] [PMID: 19863375]
Jurenka, J.S. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern. Med. Rev., 2009, 14(2), 141-153.
[PMID: 19594223]
Shehzad, A.; Lee, Y.S. Curcumin: multiple molecular targets mediate multiple pharmacological actions—a review. Drugs Future, 2010, 35, 113-119.
Buhrmann, C.; Mobasheri, A.; Busch, F.; Aldinger, C.; Stahlmann, R.; Montaseri, A.; Shakibaei, M. Curcumin modulates nuclear factor kappaB (NF-kappaB)-mediated inflammation in human tenocytes in vitro: role of the phosphatidylinositol 3-kinase/Akt pathway. J. Biol. Chem., 2011, 286(32), 28556-28566.
[] [PMID: 21669872]
Zhou, H.; Beevers, C.S.; Huang, S. The targets of curcumin. Curr. Drug Targets, 2011, 12(3), 332-347.
[] [PMID: 20955148]
Funk, J.L.; Frye, J.B.; Oyarzo, J.N.; Timmermann, B.N. Comparative effects of two gingerol-containing Zingiber officinale extracts on experimental rheumatoid arthritis. J. Nat. Prod., 2009, 72(3), 403-407.
[] [PMID: 19216559]
Ramadan, G.; El-Menshawy, O. Protective effects of ginger-turmeric rhizomes mixture on joint inflammation, atherogenesis, kidney dysfunction and other complications in a rat model of human rheumatoid arthritis. Int. J. Rheum. Dis., 2013, 16(2), 219-229.
[] [PMID: 23773648]
Ali, B.H.; Blunden, G.; Tanira, M.O.; Nemmar, A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food Chem. Toxicol., 2008, 46(2), 409-420.
[] [PMID: 17950516]
Madkor, H.R.; Mansour, S.W.; Ramadan, G. Modulatory effects of garlic, ginger, turmeric and their mixture on hyperglycaemia, dyslipidaemia and oxidative stress in streptozotocin-nicotinamide diabetic rats. Br. J. Nutr., 2011, 105(8), 1210-1217.
[] [PMID: 21144104]
Patel, M.G.; Pundarikakshudu, K. Anti-arthritic activity of a classical Ayurvedic formulation Vatari Guggulu in rats. J. Tradit. Complement. Med., 2015, 6(4), 389-394.
[] [PMID: 27774424]
Carretero, M.E.; López-Pérez, J.L.; Abad, M.J.; Bermejo, P.; Tillet, S.; Israel, A.; Noguera-P, B. Preliminary study of the anti-inflammatory activity of hexane extract and fractions from Bursera simaruba (Linneo) Sarg. (Burseraceae) leaves. J. Ethnopharmacol., 2008, 116(1), 11-15.
[] [PMID: 18155865]
Shukla, M.; Gupta, K.; Rasheed, Z.; Khan, K.A.; Haqqi, T.M. Consumption of hydrolyzable tannins-rich pomegranate extract suppresses inflammation and joint damage in rheumatoid arthritis. Nutrition, 2008, 24(7-8), 733-743.
[] [PMID: 18490140]
de Nigris, F.; Williams-Ignarro, S.; Sica, V.; Lerman, L.O.; D’Armiento, F.P.; Byrns, R.E.; Casamassimi, A.; Carpentiero, D.; Schiano, C.; Sumi, D.; Fiorito, C.; Ignarro, L.J.; Napoli, C. Effects of a pomegranate fruit extract rich in punicalagin on oxidation-sensitive genes and eNOS activity at sites of perturbed shear stress and atherogenesis. Cardiovasc. Res., 2007, 73(2), 414-423.
[] [PMID: 17014835]
Seeram, N.P.; Adams, L.S.; Henning, S.M.; Niu, Y.; Zhang, Y.; Nair, M.G.; Heber, D. In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J. Nutr. Biochem., 2005, 16(6), 360-367.
[] [PMID: 15936648]
Ahmed, S.; Wang, N.; Hafeez, B.B.; Cheruvu, V.K.; Haqqi, T.M. Punica granatum L. extract inhibits IL-1beta-induced expression of matrix metalloproteinases by inhibiting the activation of MAP kinases and NF-kappaB in human chondrocytes in vitro. J. Nutr., 2005, 135(9), 2096-2102.
[] [PMID: 16140882]
Suresh, P.; Kavitha, ChN.; Babu, S.M.; Reddy, V.P.; Latha, A.K. Effect of ethanol extract of Trigonella foenum graecum (Fenugreek) seeds on Freund’s adjuvant-induced arthritis in albino rats. Inflammation, 2012, 35(4), 1314-1321.
[] [PMID: 22395729]
Ahmadiani, A.; Javan, M.; Semnanian, S.; Barat, E.; Kamalinejad, M. Anti-inflammatory and antipyretic effects of Trigonella foenum-graecum leaves extract in the rat. J. Ethnopharmacol., 2001, 75(2-3), 283-286.
[] [PMID: 11297864]
Ashish Toppo, F.; Akhand, R.; Pathak, A.K. Pharmacological actions and potential uses of Trigonella foenum-graecum: A review. Asian J. Pharm. Clin. Res., 2009, 2(4), 29-38.
Shishehbor, F.; Rezaeyan Safar, M.; Rajaei, E.; Haghighizadeh, M.H. Cinnamon consumption improves clinical symptoms and inflammatory markers in women with rheumatoid arthritis. J. Am. Coll. Nutr., 2018, 37(8), 1-6.
[] [PMID: 29722610]
Cao, H.; Urban, J.F., Jr; Anderson, R.A. Cinnamon polyphenol extract affects immune responses by regulating anti- and proinflammatory and glucose transporter gene expression in mouse macrophages. J. Nutr., 2008, 138(5), 833-840.
[] [PMID: 18424588]
Wu, S.J.; Ng, L.T.; Lin, C.C. Cinnamaldehyde-induced apoptosis in human PLC/PRF/5 cells through activation of the proapoptotic Bcl-2 family proteins and MAPK pathway. Life Sci., 2005, 77(8), 938-951.
[] [PMID: 15964311]
Reddy, A.M.; Seo, J.H.; Ryu, S.Y.; Kim, Y.S.; Kim, Y.S.; Min, K.R.; Kim, Y. Cinnamaldehyde and 2-methoxycinnamaldehyde as NF-kappaB inhibitors from Cinnamomum cassia. Planta Med., 2004, 70(9), 823-827.
[] [PMID: 15503352]

Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy